Cargando…
Elevated levels of procoagulant microparticles in a patient with myocardial infarction, antiphospholipid antibodies and multifocal cardiac thrombosis
Circulating procoagulant microparticles (MP) are pathogenic markers of enhanced coagulability associated to a variety of disorders and released from stimulated vascular cells. When derived from endothelial cells, MP were found characteristic of thrombotic propensity in primary antiphospholipid syndr...
Autores principales: | Morel, O, Jesel, L, Freyssinet, JM, Toti, F |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1266401/ https://www.ncbi.nlm.nih.gov/pubmed/16219103 http://dx.doi.org/10.1186/1477-9560-3-15 |
Ejemplares similares
-
Microparticles in COVID-19 as a link between lung injury extension and thrombosis
por: Morel, Olivier, et al.
Publicado: (2021) -
Antiphospholipid antibodies induce proinflammatory and procoagulant pathways in endothelial cells
por: Patsouras, Markos, et al.
Publicado: (2023) -
Clinical significance of procoagulant microparticles
por: Nomura, Shosaku, et al.
Publicado: (2015) -
Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis
por: Marchandot, Benjamin, et al.
Publicado: (2021) -
Impact of Epicatechin on the Procoagulant Activities of Microparticles
por: Sinegre, Thomas, et al.
Publicado: (2020)